Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Eosinophil-Derived Neurotoxin / RNase 2: Connecting the Past, the Present and the Future

Author(s): H. F. Rosenberg

Volume 9, Issue 3, 2008

Page: [135 - 140] Pages: 6

DOI: 10.2174/138920108784567236

Price: $65

Abstract

The eosinophil-derived neurotoxin (EDN, also known as eosinophil protein-X) is best-known as one of the four major proteins found in the large specific granules of human eosinophilic leukocytes. Although it was named for its discovery and initial characterization as a neurotoxin, it is also expressed constitutively in human liver tissue and its expression can be induced in macrophages by proinflammatory stimuli. EDN and its divergent orthologs in rodents have ribonuclease activity, and are members of the extensive RNase A superfamily, although the relationship between the characterized physiologic functions and enzymatic activity remains poorly understood. Recent explorations into potential physiologic functions for EDN have provided us with some insights into its role in antiviral host defense, as a chemoattractant for human dendritic cells, and most recently, as an endogenous ligand for toll-like receptor (TLR)2.

Keywords: Inflammation, Ribonuclease, Toll-like receptor, Dendritic cell, Leukocyte


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy